XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statement Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (3,683) $ (10,149)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,731 2,817
Stock-based compensation expense 8,603 5,495
Amortization of deferred contract costs 109 72
Change in fair value of contingent consideration 410 (70)
Deferred tax benefit (620) (53)
Provision for uncollectible accounts 83 20
Non-cash interest expense 72 81
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (4,324) (839)
Unbilled receivables 1,247 1,129
Funds receivable from payment partners 34,323 9,133
Prepaid expenses, other current assets and other assets (828) 262
Funds payable to clients (60,343) (16,374)
Accounts payable, accrued expenses and other current liabilities 2,780 (3,615)
Contingent consideration (467) (4,524)
Other liabilities (413) (385)
Deferred revenue (1,526) (5)
Net cash used in operating activities (20,846) (17,005)
Cash flows from investing activities:    
Capitalization of internally developed software (1,368) (1,205)
Purchases of property and equipment (481) (102)
Net cash used in investing activities (1,849) (1,307)
Cash flows from financing activities:    
Contingent consideration paid for acquisitions (1,207) (3,320)
Payments of tax withholdings for net settled option exercises 0 (756)
Proceeds from the issuance of stock under Employee Stock Purchase Plan 864 0
Proceeds from exercise of stock options 2,144 1,071
Net cash provided by (used in) financing activities 1,801 (3,005)
Effect of exchange rates changes on cash and cash equivalents (1,202) 1,702
Net decrease in cash, cash equivalents and restricted cash (22,096) (19,615)
Cash, cash equivalents and restricted cash, beginning of period 351,177 389,360
Cash, cash equivalents and restricted cash, end of period 329,081 369,745
Supplemental disclosures of cash flow and noncash information    
Cash paid during the period for interest 0 95
Purchase of property and equipment in accounts payable 27 48
Issuance of common stock upon settlement of restricted stock units 15,072 0
Issuance of common stock for retention bonus 700 0
Cash, cash equivalents and restricted cash 329,081 369,745
Cash and Cash Equivalents    
Cash flows from financing activities:    
Cash, cash equivalents and restricted cash, end of period 327,081 365,745
Supplemental disclosures of cash flow and noncash information    
Cash, cash equivalents and restricted cash 327,081 365,745
Restricted Cash    
Cash flows from financing activities:    
Cash, cash equivalents and restricted cash, end of period 2,000 4,000
Supplemental disclosures of cash flow and noncash information    
Cash, cash equivalents and restricted cash $ 2,000 $ 4,000